{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:51:15Z","timestamp":1775065875611,"version":"3.50.1"},"reference-count":24,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Fetomaternal hemorrhage (FMH) is a common obstetrical occurrence most often associated with small volumes of blood transferred across the placenta. Fetomaternal hemorrhage leads to alloimmunization of Rh D-negative mothers, resulting in an increased risk of hemolytic disease of the newborn. Massive FMH involving volumes of blood greater than 30 mL can cause substantial fetal morbidity and mortality. Massive FMH may present with signs and symptoms such as decreased movement, sinusoidal heart rhythms, or fetal anomalies. We present 3 cases of clinically unexpected massive FMH of 206, 88, and 155 mL. The treating clinicians were unaware of any fetal or maternal signs or symptoms of FMH until contacted by the laboratory. These cases illustrate the necessity for FMH quantitation, even in the absence of clinical suspicion. Additional studies are needed to find better ways to identify these patients in advance. Development of criteria allowing identification of patients at risk would be of benefit to both mother and baby.<\/jats:p>","DOI":"10.5858\/2004-128-463-tcomfh","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T16:46:42Z","timestamp":1612975602000},"page":"463-465","source":"Crossref","is-referenced-by-count":20,"title":["Three Cases of Massive Fetomaternal Hemorrhage Presenting Without Clinical Suspicion"],"prefix":"10.5858","volume":"128","author":[{"given":"Sam","family":"Pourbabak","sequence":"first","affiliation":[{"name":"From the Departments of Internal Medicine (Drs Pourbabak and Crookston) and Pathology (Drs Rund and Crookston), University of New Mexico School of Medicine, Albuquerque"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chad R.","family":"Rund","sequence":"additional","affiliation":[{"name":"From the Departments of Internal Medicine (Drs Pourbabak and Crookston) and Pathology (Drs Rund and Crookston), University of New Mexico School of Medicine, Albuquerque"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kendall P.","family":"Crookston","sequence":"additional","affiliation":[{"name":"From the Departments of Internal Medicine (Drs Pourbabak and Crookston) and Pathology (Drs Rund and Crookston), University of New Mexico School of Medicine, Albuquerque"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3906","reference":[{"key":"i1543-2165-128-4-463-b1","series-title":"Vox Sang","first-page":"117","article-title":"Fetomaternal transplacental hemorrhage during pregnancy and after delivery.","volume":"51","author":"Bowman, J. M.","year":"1986","unstructured":"Bowman, J. M., J. M.Pollock, and L. E.Penston. Fetomaternal transplacental hemorrhage during pregnancy and after delivery.Vox Sang1986. 51:117\u2013121."},{"key":"i1543-2165-128-4-463-b2","series-title":"Transfusion","first-page":"344","article-title":"Fetomaternal hemorrhage: incidence, risk factors, time of occurrence, and clinical effects.","volume":"30","author":"Sebring, E. S.","year":"1990","unstructured":"Sebring, E. S. and H. F.Polesky. Fetomaternal hemorrhage: incidence, risk factors, time of occurrence, and clinical effects.Transfusion1990. 30:344\u2013357."},{"key":"i1543-2165-128-4-463-b3","series-title":"Int J Gynaecol Obstet","first-page":"63","article-title":"Prevention of Rh D alloimmunization.","volume":"66","year":"1999","unstructured":"ACOG practice bulletin.\n          \n          Prevention of Rh D alloimmunization.\n          No. 4, May 1999 (replaces educational bulletin No. 147, October 1990). Clinical management guidelines for obstetrician-gynecologists. American College of Obstetrics and Gynecology. Int J Gynaecol Obstet1999. 66:63\u201370."},{"key":"i1543-2165-128-4-463-b4","series-title":"J Perinatol","first-page":"227","article-title":"Massive fetomaternal hemorrhage and fetal death: are they predictable?","volume":"19","author":"Samadi, R.","year":"1999","unstructured":"Samadi, R., J. S.Greenspoon, I.Gviazda, R. H.Settlage, and T. M.Goodwin. Massive fetomaternal hemorrhage and fetal death: are they predictable?J Perinatol1999. 19:227\u2013229."},{"key":"i1543-2165-128-4-463-b5","series-title":"Int J Gynaecol Obstet","first-page":"271","article-title":"Sinusoidal fetal heart rate pattern due to massive feto-maternal transfusion.","volume":"31","author":"Rosenn, B.","year":"1990","unstructured":"Rosenn, B., A.Ben Chetrit, Z.Palti, and A.Hurwitz. Sinusoidal fetal heart rate pattern due to massive feto-maternal transfusion.Int J Gynaecol Obstet1990. 31:271\u2013273."},{"key":"i1543-2165-128-4-463-b6","series-title":"Am J Clin Pathol","first-page":"281","article-title":"Use of Rh immune globulin: ASCP practice parameter. American Society of Clinical Pathologists.","volume":"110","author":"Hartwell, E. A.","year":"1998","unstructured":"Hartwell, E. A.\n          \n          Use of Rh immune globulin: ASCP practice parameter. American Society of Clinical Pathologists.\n          Am J Clin Pathol\n          1998. 110:281\u2013292."},{"key":"i1543-2165-128-4-463-b7","series-title":"Obstet Gynecol Surv","first-page":"372","article-title":"Severe fetomaternal hemorrhage: a review.","volume":"52","author":"Giacoia, G. P.","year":"1997","unstructured":"Giacoia, G. P.\n          \n          Severe fetomaternal hemorrhage: a review.\n          Obstet Gynecol Surv\n          1997. 52:372\u2013380."},{"key":"i1543-2165-128-4-463-b8","series-title":"N Engl J Med","first-page":"798","article-title":"Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia.","volume":"338","author":"Vaughan, J. I.","year":"1998","unstructured":"Vaughan, J. I., M.Manning, R. M.Warwick, E. A.Letsky, N. A.Murray, and I. A.Roberts. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia.N Engl J Med1998. 338:798\u2013803."},{"key":"i1543-2165-128-4-463-b9","series-title":"Br J Obstet Gynaecol","first-page":"1007","article-title":"Massive feto-maternal haemorrhage: effect of passively administered anti-D in the prevention of Rh sensitization and haemolytic disease of the newborn.","volume":"95","author":"Mills, L.","year":"1988","unstructured":"Mills, L. and J. A.Napier. Massive feto-maternal haemorrhage: effect of passively administered anti-D in the prevention of Rh sensitization and haemolytic disease of the newborn.Br J Obstet Gynaecol1988. 95:1007\u20131012."},{"key":"i1543-2165-128-4-463-b10","series-title":"Cytometry","first-page":"285","article-title":"Multicenter clinical experience with flow cytometric method for fetomaternal hemorrhage detection.","volume":"50","author":"Chen, J. C.","year":"2002","unstructured":"Chen, J. C., B. H.Davis, B.Wood, and M. J.Warzynski. Multicenter clinical experience with flow cytometric method for fetomaternal hemorrhage detection.Cytometry2002. 50:285\u2013290."},{"key":"i1543-2165-128-4-463-b11","series-title":"Transfus Med","first-page":"25","article-title":"Quantification of feto-maternal haemorrhage (FMH) by flow cytometry: anti-fetal haemoglobin labelling potentially underestimates massive FMH in comparison to labelling with anti-D.","volume":"13","author":"Kennedy, G. A.","year":"2003","unstructured":"Kennedy, G. A., R.Shaw, and S.Just. et al. Quantification of feto-maternal haemorrhage (FMH) by flow cytometry: anti-fetal haemoglobin labelling potentially underestimates massive FMH in comparison to labelling with anti-D.Transfus Med2003. 13:25\u201334."},{"key":"i1543-2165-128-4-463-b12","series-title":"Br J Obstet Gynaecol","first-page":"37","article-title":"Preventing Rhesus D haemolytic disease of the newborn by giving anti-D immunoglobulin: are the guidelines being adequately followed?","volume":"104","author":"Howard, H. L.","year":"1997","unstructured":"Howard, H. L., V. J.Martlew, I. R.McFadyen, and C. A.Clarke. Preventing Rhesus D haemolytic disease of the newborn by giving anti-D immunoglobulin: are the guidelines being adequately followed?Br J Obstet Gynaecol1997. 104:37\u201341."},{"key":"i1543-2165-128-4-463-b1","series-title":"Vox Sang","first-page":"117","article-title":"Fetomaternal transplacental hemorrhage during pregnancy and after delivery.","volume":"51","author":"Bowman, J. M.","year":"1986","unstructured":"Bowman, J. M., J. M.Pollock, and L. E.Penston. Fetomaternal transplacental hemorrhage during pregnancy and after delivery.Vox Sang1986. 51:117\u2013121."},{"key":"i1543-2165-128-4-463-b2","series-title":"Transfusion","first-page":"344","article-title":"Fetomaternal hemorrhage: incidence, risk factors, time of occurrence, and clinical effects.","volume":"30","author":"Sebring, E. S.","year":"1990","unstructured":"Sebring, E. S. and H. F.Polesky. Fetomaternal hemorrhage: incidence, risk factors, time of occurrence, and clinical effects.Transfusion1990. 30:344\u2013357."},{"key":"i1543-2165-128-4-463-b3","series-title":"Int J Gynaecol Obstet","first-page":"63","article-title":"Prevention of Rh D alloimmunization.","volume":"66","year":"1999","unstructured":"ACOG practice bulletin.\n          \n          Prevention of Rh D alloimmunization.\n          No. 4, May 1999 (replaces educational bulletin No. 147, October 1990). Clinical management guidelines for obstetrician-gynecologists. American College of Obstetrics and Gynecology. Int J Gynaecol Obstet1999. 66:63\u201370."},{"key":"i1543-2165-128-4-463-b4","series-title":"J Perinatol","first-page":"227","article-title":"Massive fetomaternal hemorrhage and fetal death: are they predictable?","volume":"19","author":"Samadi, R.","year":"1999","unstructured":"Samadi, R., J. S.Greenspoon, I.Gviazda, R. H.Settlage, and T. M.Goodwin. Massive fetomaternal hemorrhage and fetal death: are they predictable?J Perinatol1999. 19:227\u2013229."},{"key":"i1543-2165-128-4-463-b5","series-title":"Int J Gynaecol Obstet","first-page":"271","article-title":"Sinusoidal fetal heart rate pattern due to massive feto-maternal transfusion.","volume":"31","author":"Rosenn, B.","year":"1990","unstructured":"Rosenn, B., A.Ben Chetrit, Z.Palti, and A.Hurwitz. Sinusoidal fetal heart rate pattern due to massive feto-maternal transfusion.Int J Gynaecol Obstet1990. 31:271\u2013273."},{"key":"i1543-2165-128-4-463-b6","series-title":"Am J Clin Pathol","first-page":"281","article-title":"Use of Rh immune globulin: ASCP practice parameter. American Society of Clinical Pathologists.","volume":"110","author":"Hartwell, E. A.","year":"1998","unstructured":"Hartwell, E. A.\n          \n          Use of Rh immune globulin: ASCP practice parameter. American Society of Clinical Pathologists.\n          Am J Clin Pathol\n          1998. 110:281\u2013292."},{"key":"i1543-2165-128-4-463-b7","series-title":"Obstet Gynecol Surv","first-page":"372","article-title":"Severe fetomaternal hemorrhage: a review.","volume":"52","author":"Giacoia, G. P.","year":"1997","unstructured":"Giacoia, G. P.\n          \n          Severe fetomaternal hemorrhage: a review.\n          Obstet Gynecol Surv\n          1997. 52:372\u2013380."},{"key":"i1543-2165-128-4-463-b8","series-title":"N Engl J Med","first-page":"798","article-title":"Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia.","volume":"338","author":"Vaughan, J. I.","year":"1998","unstructured":"Vaughan, J. I., M.Manning, R. M.Warwick, E. A.Letsky, N. A.Murray, and I. A.Roberts. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia.N Engl J Med1998. 338:798\u2013803."},{"key":"i1543-2165-128-4-463-b9","series-title":"Br J Obstet Gynaecol","first-page":"1007","article-title":"Massive feto-maternal haemorrhage: effect of passively administered anti-D in the prevention of Rh sensitization and haemolytic disease of the newborn.","volume":"95","author":"Mills, L.","year":"1988","unstructured":"Mills, L. and J. A.Napier. Massive feto-maternal haemorrhage: effect of passively administered anti-D in the prevention of Rh sensitization and haemolytic disease of the newborn.Br J Obstet Gynaecol1988. 95:1007\u20131012."},{"key":"i1543-2165-128-4-463-b10","series-title":"Cytometry","first-page":"285","article-title":"Multicenter clinical experience with flow cytometric method for fetomaternal hemorrhage detection.","volume":"50","author":"Chen, J. C.","year":"2002","unstructured":"Chen, J. C., B. H.Davis, B.Wood, and M. J.Warzynski. Multicenter clinical experience with flow cytometric method for fetomaternal hemorrhage detection.Cytometry2002. 50:285\u2013290."},{"key":"i1543-2165-128-4-463-b11","series-title":"Transfus Med","first-page":"25","article-title":"Quantification of feto-maternal haemorrhage (FMH) by flow cytometry: anti-fetal haemoglobin labelling potentially underestimates massive FMH in comparison to labelling with anti-D.","volume":"13","author":"Kennedy, G. A.","year":"2003","unstructured":"Kennedy, G. A., R.Shaw, and S.Just. et al. Quantification of feto-maternal haemorrhage (FMH) by flow cytometry: anti-fetal haemoglobin labelling potentially underestimates massive FMH in comparison to labelling with anti-D.Transfus Med2003. 13:25\u201334."},{"key":"i1543-2165-128-4-463-b12","series-title":"Br J Obstet Gynaecol","first-page":"37","article-title":"Preventing Rhesus D haemolytic disease of the newborn by giving anti-D immunoglobulin: are the guidelines being adequately followed?","volume":"104","author":"Howard, H. L.","year":"1997","unstructured":"Howard, H. L., V. J.Martlew, I. R.McFadyen, and C. A.Clarke. Preventing Rhesus D haemolytic disease of the newborn by giving anti-D immunoglobulin: are the guidelines being adequately followed?Br J Obstet Gynaecol1997. 104:37\u201341."}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"link":[{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/128\/4\/article-p463.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/128\/4\/463\/2754169\/1543-2165(2004)128_463_tcomfh_2_0_co_2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/128\/4\/article-p463.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/128\/4\/article-p463.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T01:10:18Z","timestamp":1770772218000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/128\/4\/article-p463.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":24,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.5858\/2004-128-463-tcomfh","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}